Reduced fibrous capsule elastic fibers from biologic ECM-enveloped CIEDs in minipigs,supported with a novel compression mechanics model

Abstract

BACKGROUND:

Fibrous capsules (Fb) in response to cardiovascular implantable electronic devices (CIEDs), including a pacemaker (P) system, can produce patient discomfort and difficulties in revision surgery due partially to their increased compressive strength, previously linked to elevated tissue fibers.

OBJECTIVE:

A preliminary study to quantify structural proteins, determine if biologic extracellular matrix-enveloped CIEDs (PECM) caused differential Fb properties, and to implement a realistic mechanical model.

METHODS:

Retrieved Fb (-P and -PECM) from minipigs were subjected to biomechanical (shear oscillation and uniaxial compression) and histological (collagen I and elastin) analyses.

RESULTS:

Fb-PECM showed significant decreases compared to Fb-P in: low strain-loss modulus (390 vs. 541 Pa) across angular frequencies, high strain-compressive elastic modulus (1043 vs. 2042 kPa), and elastic fiber content (1.92 vs. 3.15 μg/mg tissue). Decreases in elastin were particularly noted closer to the implant’s surface (Fb-PECM = 71% vs. Fb-P = 143% relative to dermal elastin at mid-tangential sections) and verified with a solid mechanics hyperelasticity with direction-dependent fiber viscoelasticity compression simulation (r ² ≥ 98.9%).

CONCLUSIONS:

The biologic envelope composed of decellularized porcine small intestine submucosa ECM for CIEDs promoted fibrous tissues with less elastic fibers. Novel compression modeling analyses directly correlated this singular reduction to more desirable subcutaneous tissue mechanics.

Keywords

Minipig study cardiovascular implantable electronic devices pacemaker decellularized tissue ECM biologic envelope foreign body reaction fibrous tissue encapsulation compression biomechanics oscillation rheology elastin and elastic fibers 3D distribution COMSOL multiphysics hyperelastic simulation

1. Introduction

The formation of fibrous capsules is a foreign body reaction (FBR) against nondegradable materials, long-term implanted into the host system, dependent on factors including the material’s physical and chemical surface properties [1–4]. This tough tissue is induced to wall-off and systemically-isolate foreign objects (like cardiovascular implantable electronic devices (CIEDs) [5] with titanium housing and their polymer-coated leads) and is a general indicator for implant biocompatibility: the thinner the layer, the more compatible the material [3,6,7]. The fibrous capsule (also called fibrotic scar tissue or fibrosis) is distinct from other tissue types in the subcutaneous space and is mainly composed of compact collagen fibers produced by activated fibroblasts. The capsule can also contain layers of loose granulation tissue, immune cells, vessels, and a variety of enzymes and signaling molecules [1,8,9]. Aside from collagen (mainly type I, with occasional types II and III) [10–12], fibrous capsules have other extracellular matrix (ECM) structures, most notably elastic fibers [1,9,13,14]. Elastic fibers are responsible for elastic recoil after stretching and compression for reversible recovery after deformation caused by applied loads, particularly beneficial for skin and blood vessels [15–17]. However, in fibrous capsules surrounding medical implants, their presence in excess may be detrimental to the tissue mechanics. An elastic fiber’s major component (∼90%) is elastin. Initially, the relatively small (M _w ∼ 60 kDa) soluble precursor tropoelastin is secreted by cells (such as fibroblasts), which then assembles and is crosslinked (forming covalent bonds) into elastic fibers via elastogenesis. Lysyl oxidase (and related enzymes) oxidize lysine residues for crosslinking with other tropoelastins and ECM proteins including collagens.

The fibrous capsule FBR is dynamic (time-dependent) and constantly remodeled depending on the stimuli. CIED-induced fibrous tissues can be used to an advantage: to subcutaneously affix and prevent device migration [18–21]. Conversely, too much fibrosis causes unwanted scar appearance, local tissue hardness, high compressive strength, and difficulties during CIED generator changes and pacing lead revision surgeries [22–26]. In patients with silicone breast implants, contracture, which induces increased stiffness, discomfort, and pain, can be attributed in part to increased elastin expression [13,16,27]. Similarly, issues encountered with CIEDs may be due to the overabundance of elastic fibers. Biologic ECM envelope products composed of decellularized porcine small intestine submucosa (SIS) were developed [28–30] to potentially mitigate the fibrous response. Besides acting as a cover for the CIED surface, SIS ECM implants are rich in bioactive growth factors, glycosaminoglycans, and structural proteins that can affect the subcutaneous microenvironment and FBR [31–35]. To investigate their underlying effect, this study compared fibrous capsule biomechanical and histological properties and associated elastic fiber distribution from pacemakers without and with biologic ECM envelopes in a short-term minipig subcutaneous model. A computer model was proposed and fitted to explain and verify the observed compressive stress-strain responses and correlate them to elastin amounts and arrangements.

2. Materials and methods

2.1. Animals and fibrous dissection

Surgical procedures and animal care were conducted at an independent research organization (American Preclinical Services, Minneapolis, MN, USA). Protocols were approved by the Institutional Animal Care and Use Committee (IACUC), and animals received humane care in compliance with NIH guidelines [36]. Human pacemakers (pulse generators) with an attached, coiled pacing lead (Edora 8 SR-T and Solia JT 45, Biotronik, Lake Oswego, OR, USA), without (P) and with decellularized SIS ECM (PECM) envelopes (CanGaroo^® Envelope (medium: 6.9 cm × 6.5 cm = area of 44.85 cm²), Aziyo Biologics, Silver Spring, MD, USA) were implanted subcutaneously (at 8 per group) in contralateral ventral neck-chest areas of adult miniature pigs (minipigs), then sacrificed and necropsied for a total of 3 months duration (based on [19]). Implants that failed before the endpoint were excluded from this study. After pacemaker retrieval (Fig. 1), the surrounding fibrous capsule (Fb) and adjacent adipose (Ad) with occasional underlying muscle tissue were excised, trimmed, and assigned as groups (Fig. 2): Fb-P (fibrous tissue from pacemaker only, n = 5) and Fb-PECM (fibrous tissue from pacemaker in ECM envelopes, n = 2), with Ad (adipose, n = 4) control, where n = biological replicates (individual animals). Multiple technical replicates (≥3) were obtained per biological replicate per test to account for individual variability [37]. These groups and sample sizes were used in subsequent experiments.

Fig. 1.

A pacemaker model (top left) implanted in the subcutaneous pocket (bottom left) with the subsequent fibrous capsule (Fb) response (bottom center). After retrieval (bottom right), select Fb with distinct inner and outer surfaces was cut into cross and tangential (in, mid, and out) sections (top right).

Fig. 2.

Images of Fb-P (fibrous tissue from pacemaker only, n = 5), Fb-PECM (fibrous tissue from pacemaker in ECM envelope, n = 2), and Ad (adipose control) surrounding tissues. Fibrous tissues are located inside the dashed outlines for both samples labeled “1”. *Fb-P samples: 1–3 and Fb-PECM: 2 had pronounced fibrous connective tissue appearance. ^#Fb-P: 1, 3, and 5, and Fb-PECM: 1 had some regions of hematoma.

2.2. Shear oscillation rheology

Tissues were subjected to rotating shear oscillation at exponentially increasing angular frequencies (𝜔) per fixed maximum shear strain (𝛾) to obtain their viscoelastic properties: storage modulus (G ^′), loss modulus (G ^′′), delta or shear stress to strain phase shift (𝛿) = tan⁻¹(tan(𝛿)) in degrees from 0° (pure solids) to 90° (pure liquids), and dynamic modulus (magnitude of complex modulus (G ^∗ = G ^′ + iG ^′′) = |G ^∗|) = (G ^′2 + G ^′′2)^0.5 = G ^′∕cos(𝛿). Cylindrical biopsies at 8 mm-diameter (d) (Fb inner surface down and outer surface up) were tested in DHR-2 (Discovery Hybrid 2, TA Instruments, New Castle, DE, USA) using parallel plates with a probe d = 12 mm and gap assigned to 2 mm. Oscillation experiments were performed at 5% (low) and 40% (high) 𝛾 from 1–40 rad/s (0.16–6.34 Hz) 𝜔.

2.3. Axial compression

Unconfined uniaxial compression was conducted to obtain [38]: true compressive stress (𝜎), strain (𝜀), and elastic modulus (E) = Δ𝜎∕Δ𝜀 at 0–10% (low) and high 30–40% (high) 𝜀. Samples with d = 8 mm and height (h) = entire Fb thickness were placed onto the baseplate (Fb inner surface down and outer surface up) and compressed with a 6 mm chamfered indenter at 0.1 mm/s until ∼40–60% 𝜀 (Instron 3345, Norwood, MA, USA). Instantaneous E = d𝜎∕d𝜀 = numerical derivative of 𝜎 with respect to 𝜀 was reported (centered finite difference with a 2-term Taylor: (d𝜎∕d𝜀)_i = (−𝜎_i+2 +8𝜎_i+1 −8𝜎_i−1 + 𝜎_i−2)∕12(𝜀_i −𝜀_i−1) [39]) to better display changes in 𝜎 = f (𝜀).

2.4. Soluble elastin

Fastin^TM elastin assay (Biocolor, Carrickfergus, Northern Ireland, UK) [40,41] quantified elastic fibers (EFs) via released water-soluble 𝛼-elastin from tissues. Fresh specimens were processed through 𝛼-elastin extraction (100°C in 0.25 M oxalic acid), precipitation, and complexation with 5,10,15,20-tetraphenyl-21H,23H-porphine tetrasulfonate (TPPS). The complex was recovered, TPPS released, absorbance at 513-nm measured, converted to mass using standards, and normalized to tissue mass (compared to a pig skin positive control). The assay was deemed reliable if the obtained ratio of elastin in the skin control was around the expected 3.5 μg/mg [40].

2.5. Tissue staining

Fb samples were processed for histology to determine microscopic thickness, morphology, and structure using Masson’s trichrome [42] (MT, Trichrome Stain Kit ab150686, Abcam, Waltham, MA, USA) [43] for connective tissue components (cell nuclei = purple, cytoskeleton = red, and tissue collagen = blue), Van Gieson’s elastic (VGE, Elastic Stain Kit ab150667, Abcam) [44] for EFs (black strands), and immunohistochemistry (IHC) for detection (brown signals) of collagen type I (1:100 anti-human collagen I alpha-1 1200-1450 fragment (ab233080, Abcam) compatible to pig elastin [45]) and EF elastin (1:200 anti-pig and human elastin (ab21610, Abcam)) [41,46,47]. The 3D differential distribution of elastin was investigated using four 2D: one cross and three tangential (inner (in), middle (mid), and outer (out) surface) sections (Fig. 1).

Briefly, tissues were fixed in 10% neutral buffered formalin, stored in 70% ethanol (EtOH), trimmed, dehydrated in increasing EtOH then xylene, and paraffin-embedded (Paraplast X-TRA^®, Sigma-Aldrich, St. Louis, MO, USA). Paraffin blocks were sectioned (at 5-μm), placed on slides, and rehydrated. After staining with MT and VGE, samples were dehydrated and soaked in Histomount (Thermo Fisher Scientific, Waltham, MA, USA). For IHC, rehydrated sections (1 negative (–) control and ≥1 experimental/slide) with dried boundaries were circled with a hydrophobic barrier (ImmunoPen, Sigma-Aldrich). Endogenous peroxidase inhibition and antigen retrieval (citrate pH 6 at 95°C for 10 min) was performed before blocking with 10% normal goat serum. Specimens were hybridized with 1° antibody (Ab) for 2 hours (while blocking buffer alone was used for (–)), processed with rabbit specific HRP/DAB (ABC) Detection IHC Kit (ab64261, Abcam) [48], and mounted in ImmunoHistoMount (Sigma-Aldrich). Human skin (Sigma-Aldrich and Aziyo Biologics) (comparable to pig skin [49]) and ECM envelope (Aziyo Biologics) samples were included as controls.

Images were captured in Cytation 5 (Agilent, Santa Clara, CA, USA) and processed with ImageJ (NIH, Bethesda, MD, USA). IHC area ratios were quantified in thresholded and leveled images using ImageJ’s analyze particle area sum over polygonal tissue area selection. Individual slide (–) signals were subtracted.

2.6. Modeling of compression

COMSOL Multiphysics (COMSOL, Stockholm, Sweden) using the solid mechanics interface with nonlinear structural materials module was employed to generate a 3D time-dependent compression model matching the experimental using parameters: Fb (E = 295 kPa (determined through parametric sweep), density (𝜌) = 1.05 g/mL, and Poisson’s ratio (𝜈) = 0.4999) and EF properties (E = 400 kPa (calculated based on [50]) and 𝜌 = 1.2 g/mL). Fb was assumed as neo-Hookean hyperelastic incompressible [51]. EFs were modeled with direction-dependent (tangential and axial) domain node fibers (linear elastic with a volume fraction or ratio (r _v)). The tissue was divided into sections (in, mid, and out) and each assigned with fibers with viscoelasticity of a single-branch generalized Maxwell containing: energy factor (f _e) and relaxation time (t _r) [50]. A rigid indenter at 0.1 mm/s prescribed velocity compressed Fb with constrained bottom boundary to 40%. Unstructured uniformly-distributed quadrilateral meshes along h were used. Average of the domain’s top boundary in contact with the probe was evaluated for stress = Gauss point von Mises stress and strain = displacement/h.

2.7. Data analysis

Data were processed in Excel (Microsoft) and MATLAB (Mathworks, Natick, MA, USA). Technical replicate values were averaged, and biological replicates’ values again averaged then reported as mean ± standard deviation. Student’s t-test and analysis of variance (ANOVA, 1 and 2-factor) with Tukey-Kramer were used for comparison using a probability (p) < 0.05 deemed significantly different and represented as: ***p < 0.001, **p < 0.01, and *p < 0.05.

3. Results

3.1. Fibrous capsule gross evaluation

Implants induced Fb tissues (Fig. 1) in the subcutaneous region. The fibrous appearance was prominent in 3/5 (60%) and 1/2 (50%) for Fb-P (samples 1–3) and Fb-PECM (2), respectively (Fig. 2). These dissected fibrous capsule tissues varied in thicknesses in situ from ∼2 to 6 mm within each sample and across biological replicates. They were attached to adipose (Ad) tissues on their outer surfaces, while their inner surfaces (adjacent to implant) were smooth, slippery, and lined with interstitial fluid. Localized blood patches (subcutaneous hematoma) were observed on inner sides in 3/5 (60%) and 1/2 (50%) of Fb-P (samples 1, 3, and 5) and Fb-PECM (sample 1), likely due to the surgical procedure. No signs of swelling were noticed.

Fig. 3.

(a) Storage (G ^′) and loss (G ^′′) moduli vs. angular frequency (𝜔) in a log–log plot at 5% and 40% maximum shear strain (𝛾) of Fb-P (blue) and Fb-PECM (green). G ^′′, 5% 𝛾: Fb-P > Fb-PECM (*p < 0.05). (b) Log–log (5% 𝛾) of dynamic modulus (|G ^∗|) vs. 𝜔. Ad (yellow) > Fb (***p < 0.001) (c) Phase shift (𝛿) bar at 5% 𝛾 and 1, 10, and 40 rad/s 𝜔.

3.2. Response to periodic shear

Fb tissues subjected to 5% 𝛾 oscillation showed G ^′ > G ^′′ (Fig. 3a), indicating a more solid elasticity with 𝛿 < 45° (Fig. 3c), generally independent of 𝜔. G ^′ and G ^′′ displayed parallel plots due to their undamaged structures (nondestructive condition). The deformation was small to remain in the linear viscoelastic region (where data deemed reliable). The |G ^∗| (resultant of G ^′ and G ^′′) for Fb (P vs. PECM) were similar (p = 0.063), but fibrous capsules had lower (***p < 0.001) |G ^∗| than adipose tissues (Fig. 3b); showing these connective tissue types can easily be distinguished. Importantly at low 𝜸, Fb-PECM’s G ^′′ was statistically lower (*p = 0.029) compared to Fb-P’s (Fig. 3a, Table 1).

Table 1
Fibrous (Fb) subcutaneous tissue properties with significant difference

Material property Fb-P Fb-PECM p

G ^′′ [Pa], at low-𝛾 shear oscillation 541 ± 54 390 ± 40 0.029

E [kPa], at high-𝜀 compression 2042 ± 442 1043 ± 507 0.026

Released 𝛼-elastin from tissue [μg/mg] 3.15 ± 0.90 1.92 ± 0.33 0.036

Elastin in tissue section [%]:

Cross 13.2 ± 1.1 8.6 ± 2.2 0.011

Mid-tangential 12.6 ± 2.2 6.2 ± 1.6 *0.024

Material property	Fb-P	Fb-PECM	p
G ^′′ [Pa], at low-𝛾 shear oscillation	541 ± 54	390 ± 40	*0.029
E [kPa], at high-𝜀 compression	2042 ± 442	1043 ± 507	*0.026
Released 𝛼-elastin from tissue [μg/mg]	3.15 ± 0.90	1.92 ± 0.33	*0.036
Elastin in tissue section [%]:
Cross	13.2 ± 1.1	8.6 ± 2.2	*0.011
Mid-tangential	12.6 ± 2.2	6.2 ± 1.6	*0.024

At 40% 𝛾, G ^′ trended at <G ^′′ (Fig. 3a) and 𝛿 > 45° (49–67° spread), showing materials with dominant fluid-like and viscous properties. The high 𝛾 led to stretching which appeared to release bound water molecules and influence the elevated loss modulus. Pairwise G ^′ and G ^′′ demonstrated similarities despite an apparent lower pattern for Fb-PECM.

3.3. Effect of compression

Macroscopic thicknesses (for strain calculation) using a caliper yielded 4.0 ± 1.1 for Fb-P and 3.3 ± 0.5 mm for Fb-PECM, but still statistically similar (p = 0.59).

Compression to high strains (some up to ∼60%) led to reversible deformation within the elastic region even with nonlinearity of the 𝜎-𝜀 curves. Ad had drastically lower 𝜎 and its derivative (d𝜎∕d𝜀) compared to both Fb’s (Fig. 4a–b), which rendered to lower (***p < 0.001 at 0–10% and at least *p < 0.05 at 30–40% 𝜀) compressive E (Fig. 4c).

Fig. 4.

(a) True compressive stress (𝜎) vs. strain (𝜀) in semi-log of Fb-P (blue), Fb-PECM (green), and Ad (black/yellow) technical replicates. Ad trended < Fb. Fb-P’s curvature looks different compared to Fb-PECM and Ad’s, highlighted in the next graph. (b) Semi-log of instantaneous elastic modulus (d𝜎∕d𝜀) vs. 𝜀, indicating 0–10% (gray) and 30–40% (black double arrows) regions. (c) Compressive elastic modulus (E) at 0–10% (top) and 30–40% (bottom) 𝜀. Pairwise significance: *p < 0.05 and ***p < 0.001, notably: Fb-P > Fb-PECM at 30–40% 𝜀.

It is remarkable that Ad and Fb-PECM’s curves had generally similar semi-log shapes (with adipose just translated downwards), while Fb-P’s exhibited a distinct pattern (Fig. 4a) and more noticeable in numerical differentiation (Fig. 4b blue curves). Quantitatively at high 𝜺 (30–40% or higher), Fb-P had significantly greater (*p = 0.026) slope or stiffer E than Fb-PECM (Fig. 4c, Table 1).

3.4. Amount of 𝛼-elastin

Fibrous tissues were detected to contain more (**p = 0.002 for Fb-P and *p = 0.011 for Fb-PECM) elastin compared to adipose (Fig. 5). Importantly, Fb-P had statistically higher (*p = 0.036) tissue elastin than Fb-PECM (Fig. 5b, Table 1), indicating observed biomechanics differences were influenced by elastic fibers.

Fig. 5.

(a) Reddish-brown TPPS after release from 𝛼-elastin pellet. (b) Normalized elastin-to-tissue mass ratio of the two Fb groups, Ad, and a skin control. Pairwise significance: *p < 0.05 and **p < 0.01, importantly: Fb-P > Fb-PECM.

3.5. Histology analysis

Sections of the samples from both Fb groups showed collagen secreted by activated fibroblasts, filling the entire thickness with interspersed blood vessels (Fig. 6). Fb-PECM stained their cell nuclei faint and ECM lighter even after several repeats, perhaps due to differences in chemistry. Additionally for Fb-PECM, there were no signs of remnant ECM envelope suggesting full remodeling of the SIS. No foreign body giant cell was noticed indicating the absence of chronic inflammation. In some sections, adipose tissue can be seen in the mid to outer zones, which indirectly indicated fibrous formation originating from the implant’s surface. Regions with hematoma demonstrated reddish coloration in MT with round nuclei and brownish in VGE, likely as macrophages and blood, found in the inner surface.

Fig. 6.

Connective tissue stains: Masson’s trichrome (MT) and Van Gieson’s (VGE) of representative Fb cross-sections with layers spanning from the implant-adjacent inner to the outer surface attached to Ad. Human skin VGE with epidermis and dermis tissues included as controls. Boxed insets demonstrate magnified regions with fibroblasts, collagen ECM (blue in MT), and elastic fibers (black strands in VGE).

Microscopic thicknesses (2.7 ± 1.1 for Fb-P, 2.2 ± 0.3 for Fb-PECM, and 2.3 ± 0.1 mm for skin) were statistically similar (p = 0.89). Interestingly, the overall morphology of fibrous capsules resembled the skin dermis (Fig. 6 VGE).

Elastic fibers (EFs) were detected as black strands and visually more present in cross-sections of Fb-P, especially in regions closer to the inner surface (Fig. 6 VGE inset). Immunostaining confirmed higher (*p = 0.011) differentially-expressed EF elastin in Fb-P vs. Fb-PECM (Fig. 7, Table 1, 1.49 ± 0.12 and 0.98 ± 0.25 relative to dermis control levels). In tangential cuts (Fig. 7a boxed), there appeared to be more elastin in Fb-P (and in dermis) vs. Fb-PECM at inner and mid zones. Statistically, Fb-P > Fb-PECM (*p = 0.024) at mid-tangential (Fig. 7b, Table 1). Fb sections showed various stages of elastogenesis, ranging from diffuse elastin staining to assembled EFs with different orientations. The biologic ECM envelope displayed lower (*at least p < 0.05) background elastin compared to others.

Fig. 7.

(a) Representative elastin-IHC sections with negatives (–) from the two Fb groups and biologic ECM envelope and skin (showing epidermis and dermis tissues) controls. Visually, Fb-P > Fb-PECM for in- and mid-tangential and cross-sections staining. (b) Elastin in tissue area ratio compared to dermis bar graph. Mid-tangential and cross-sections: Fb-P (blue) > Fb-PECM (green) (*p < 0.05). ECM envelope (orange) < all other groups (*p < 0.05).

Collagen type I is prominent among all tissue groups: Fb-P, Fb-PECM, ECM envelope, and dermis controls were found to be statistically similar (p = 0.81) (Fig. 8). Its density was qualitatively more intense in bundles observed in the dermis (Figs 6, 8a). Conversely, collagen I in fibrous capsules did not appear bundled but as separate fibers, suggesting less organization and maturation. EFs did not colocalize with collagen I in Fb samples.

Fig. 8.

(a) Collagen I-IHC cross-sections from Fb groups, ECM envelope, and skin dermis. (b) Bar of collagen I in tissue area ratio with 47–55% range with no significant differences between groups.

3.6. Computer simulation

Simulation with 6-fold axially-oriented fibers at the inner and mid-Fb (in + 1/3 mid) relative to 12% r _v of tangential whole-tissue fibers (with consistent EF properties) resulted in a compressive 𝜎-𝜀 curve that agreed well (r ² = 99.7%) compared to experimental Fb-P observation, including elevated von Mises stress seen across tissue equivalent to higher compressive strength (Fig. 9a). When these axial elastic fibers were removed (at 0 fiber, Fig. 9b–c), the plot fitted accurately to Fb-PECM experimental (Fig. 9d, r ² = 98.9%). Different iterations of domain material models were simulated (Fig. 9e), but ultimately the hyperelastic with regional viscoelastic direction-dependent fibers showed the best for modeling Fb-P and Fb-PECM which agreed with experimental trends relating compression (Figs 4a, 9d) to differential elastic fiber expression (Figs 5b, 6, 7) using the viscoelasticity parameters: f _e = 2% and t _r = 50 s.

Fig. 9.

(a) Graphical 3D of von Mises stress and deformation of Fb compression simulation at 40% 𝜀. (b) Compressive stress (𝜎) vs. axial fiber amount, indicating 0 for Fb-PECM and 6 for Fb-P. (c) Locations and directions of fibers in Fb domains. (d) Nonlinear scatterplot of 𝜎 vs. 𝜀, displaying good agreement between Fb experimental (Exp) and simulation (Sim) values. (e) 𝜎 vs. 𝜀 Sim curves of various material models.

4. Discussion

4.1. Biologic ECM envelopes mitigate elastic fiber formation and fibrous tissue stiffness

The fibrous capsule response was influenced by host contact to implant surface materials: titanium housing of pulse generator, epoxy resin of connector receptacle, silicone rubber of sealing plug, silicone rubber and polyurethane cover of pacing lead, and decellularized porcine SIS ECM of the envelope [28,52]. It is noted that pacing leads were coiled around the pulse generator in this study (together influencing the fibrous capsule formation), while in clinical usage, leads are extended and implanted towards the heart muscles. In this scenario, the pulse generator and pacing leads will induce separate fibrotic responses. Fibrous capsules are generated from activated fibroblasts which can originate from different locations within the skin including as hypodermal fibroblast residing in the adipose tissue [53].

Macro and micro-histologic features of recovered and processed fibrous tissues, without or with the biologic ECM envelope treatment, indicate differing degrees of FBR biocompatibility, previously observed in a rabbit model [54]. As expected from prior animal studies, both implant groups induced varying levels of fibrous tissues prominent in collagen I [10–12,55]. Despite similarities in appearance, thickness, and collagen type I morphology and content, we found five properties with statistically less magnitudes from Fb-PECM samples, summarized in Table 1. Compared to biopsied tissue thickness measurements of 4.0 and 3.3 mm for Fb-P and Fb-PECM, respectively, histological samples (at 2.7 and 2.2 mm) were apparently thinner because of shrinkage during the ethanol dehydration steps.

Changes in biomechanics at specific strain conditions, as seen at low-𝛾 shear oscillation and high-𝜀 compression, can be explained by the anisotropic [56] levels of tissue elastin, which constitute the mature functional form of load-bearing elastic fibers. Elastic fibers are abundant in the capsular tissue from several other different subcutaneous implant studies [1,9,13,14]). High-strain E of Fb-P tissue samples compressed at ∼30% were well within the 1.6–5.7 MPa of silicone implant fibrous capsules collected from breast capsular contracture patients [13]. E values for Ad control tissue fell within the acquired spread from human adipose [57], supporting that our tests were sound and accurate. Use of the biologic ECM envelope significantly lowered Fb-ECM levels of elastin and elastic fibers versus Fb-P, particularly in tissue regions close to the pacemaker and leads. The reduction strongly correlated with a drop in E below Fb-P and the previously reported range of undesirable tissue from breast capsular contracture. Since this study only had a short 3-month duration, mechanical differences between the Fb-ECM and Fb-P groups should widen over time as elastic fibers continue to accumulate at a faster rate in the Fb-P group, pushing the mechanical properties to match tissue from the most severe cases of contracture. These data suggest biologic ECM envelopes could be used to alter the FBR for subcutaneous implants and mitigate excess accumulation of structural components, like elastic fibers, in the fibrous tissue that increase tissue elastic modulus and cause contraction.

Reducing tissue stiffness following subcutaneous implantation surgeries may improve patient comfort and long-term clinical outcomes. For patients receiving CIEDs, a hard fibrotic tissue can cause lead dislodgment [58,59]. Tissue with higher stiffness values encasing generator and/or leads also increases the difficulty of revision procedures and contributes to higher complication rates observed for revision procedures compared to those reported for de novo implantations [24,25,60,61]. Using biologic ECM envelopes to wrap CIEDs and modify the FBR could be an effective method to reduce these complications and improve patient health.

4.2. Novel compression modeling effectively simulates fibrous tissue from CIED FBRs

In compression testing of fibrous capsules reported in previous studies, excess collagen levels confounded the mechanical effects of elastic fibers. With statistically similar levels and orientation of collagen between this study’s two tissue groups, the role of elastic fibers could be isolated in computer modeling. In the proposed hyperelastic model with viscoelastic fibers (Fig. 9), Fb-PECM was set as the starting fibrous tissue baseline, assuming at the early timeline of Fb-P’s development that ultimately produced more elastic fibers. For this domain baseline, the simulated compressive stress-strain curve agreed with experimental once elastic fiber orientation was assigned as force-orthogonal (tangential or radial) and its tissue volume fraction to 12%, within acceptable degree of variability to the observed 8.6% (in cross-section immunohistochemistry). Addition and successive increase of force-parallel (axial) fibers to 6 times greater in the inner 44% region then created the accurate Fb-P compression model. The fiber ratio ultimately plateaued to around 7-fold maximum capacity, indicating peak resemblance to the dermal control and correlating with the similarities in elastin quantity and histology, which possibly signifies a similar tissue genesis. It is noted that fibers placed closer to the implant provided better simulation outcome with higher stress-strain influence than the mid and outer zones. Overall, evidence considering statistics, potential sources of error, visual, and modeling analyses suggest that more elastic fibers are found toward the CIED surface in Fb-P. This also resulted in higher loss modulus taken in the rheology experiment due to elastic fiber-dependent increased water absorption and tissue retention [16,62].

The biological importance of elastic fiber’s localized expression and orientation is highlighted in a few skin studies involving normal versus diseased or altered histological states. In healthy young skin, elastic fibers are normally arranged perpendicular (or axial) to the surface, specifically in the papillary or upper dermis directly underneath the epidermis [63,64]. Aging caused significant decrease in these organized structures which led to changes in skin’s biomechanical performance [63]. Malignant melanoma associated with fibrosis shifted and increased the quantity of elastic fibers, instead, more towards the reticular or lower dermis, with prevalent parallel (or tangent) directionality [64]. Similarly, in patients with morphea, characterized by thick and hardened skin patches, there is an increased parallel elastic fibers in the reticular dermal tissue [65], possibly for stronger shear resistance. The organizational orientation of groups of ECM fibers is naturally to resist directional loads. The inferred trend in the dermis-like fibrous capsule, supported by our computer model (in Fb-P), is that the closer to the hard surface (such as the titanium pulse generator CIED case), the higher the axially-directed elastic fibers to withstand the dominant compressive stimuli. Addition of the polymeric SIS (in Fb-PECM) that absorbs water provided damping and shock-absorbing effects, lessening the need to resist compression and thus the amount of surface-perpendicular elastic fibers.

5. Conclusions

CIEDs wrapped in the biologic ECM envelope reduced elastic fibers in the fibrous capsule region close to the implant, which directly led to a more subtle biomechanical response including lower compressive strength with some likeness to surrounding adipose tissue. Novel mechanical modeling highlighted the potential of this envelope for improved clinical outcomes of CIED implantations. A long-term study with more biological replicates for investigating elastic fiber anisotropy and associated cells and structures can be conducted in the future.

Footnotes

Acknowledgements

The authors thank their research group undergraduates: Mariana Cabral, Megan Forst, Jayda Lewis, Andrew Tarabokija, Henna Chaudhry, and Evan Carroll for their lab assistance and feedback, Dr. Michael Dores (Biology) for help and access to imaging resources, and the Engineering Department and Hofstra University staff, especially Lori Castoria, Lynne Espiritu, Liz Downey, and Dean Sina Rabbany for overall support.

Conflict of interest

None to report.

Funding

Partial funding was obtained through the Aziyo Biologics research grant.

References

Klopfleisch

and Jung

, The pathology of the foreign body reaction against biomaterials, J Biomed Mater Res A 105(3) (2017), 927–940.

Socarras

T.O.

Vasconcelos

A.C.

Campos

P.P.

Pereira

N.B.

Souza

J.P.

and Andrade

S.P.

, Foreign body response to subcutaneous implants in diabetic rats, PLoS One 9(11) (2014), e110945.

Chung

Maestas Jr.

D.R.

Housseau

and Elisseeff

J.H.

, Key players in the immune response to biomaterial scaffolds for regenerative medicine, Advanced Drug Delivery Reviews 114 (2017), 184–192.

Veiseh

and Vegas

A.J.

, Domesticating the foreign body response: Recent advances and applications, Advanced Drug Delivery Reviews 144 (2019), 148–161.

Steffen

M.M.

Osborn

J.S.

and Cutler

M.J.

, Cardiac implantable electronic device therapy: Permanent pacemakers, implantable cardioverter defibrillators, and cardiac resynchronization devices, Med Clin North Am 103(5) (2019), 931–943.

Welch

N.G.

Winkler

D.A.

and Thissen

, Antifibrotic strategies for medical devices, Advanced Drug Delivery Reviews 167 (2020), 109–120.

Gardner

A.B.

Lee

S.K.

Woods

E.C.

and Acharya

A.P.

, Biomaterials-based modulation of the immune system, Biomed Res Int 2013 (2013), 732182.

Hernandez

J.L.

Park

Yao

Blakney

A.K.

Nguyen

H.V.

Katz

B.H.

, Effect of tissue microenvironment on fibrous capsule formation to biomaterial-coated implants, Biomaterials 273 (2021), 120806.

Wagner

Elbert

S.S.

Zhang

and Yaszemski

, Biomaterials Science: An Introduction to Materials in Medicine, Fourth edn, Academic Press is an imprint of Elsevier, San Diego, 2020, pages cm p.

10.

Yang

Y.H.

Ard

M.B.

Halper

J.T.

and Barabino

G.A.

, Type I collagen-based fibrous capsule enhances integration of tissue-engineered cartilage with native articular cartilage, Ann Biomed Eng 42(4) (2014), 716–726.

11.

Brodsky

and Ramshaw

J.A.

, Collagen organization in an oriented fibrous capsule, Int J Biol Macromol 16(1) (1994), 27–30.

12.

Akilbekova

and Bratlie

K.M.

, Quantitative characterization of collagen in the fibrotic capsule surrounding implanted polymeric microparticles through second harmonic generation imaging, PLoS One 10(6) (2015), e0130386.

13.

Poh

P.S.P.

Schmauss

McGovern

J.A.

Schmauss

Chhaya

M.P.

Foehr

, Non-linear optical microscopy and histological analysis of collagen, elastin and lysyl oxidase expression in breast capsular contracture, Eur J Med Res 23(1) (2018), 30.

14.

Hiebl

Hopperdietzel

Hunigen

Dietze

Jung

and Niehues

S.M.

, Tissue reaction induced by implanted venous access ports in adult patients after infection of the implantation site, Clin Hemorheol Microcirc 58(1) (2014), 107–113.

15.

Vindin

Mithieux

S.M.

and Weiss

A.S.

, Elastin architecture, Matrix Biol 84 (2019), 4–16.

16.

Mithieux

S.M.

and Weiss

A.S.

, Elastin, Adv Protein Chem 70 (2005), 437–461.

17.

Baumann

Bernstein

E.F.

Weiss

A.S.

Bates

Humphrey

Silberberg

, Clinical relevance of elastin in the structure and function of skin, Aesthet Surg J Open Forum 3(3) (2021), ojab019.

18.

Ursaru

A.M.

Haba

C.M.

Popescu

S.E.

Crisu

Petris

A.O.

and Tesloianu

N.D.

, A rare entity-percutaneous lead extraction in a very late onset pacemaker endocarditis: Case report and review of literature, Diagnostics (Basel) 11(1) (2021), 96.

19.

Robotti

Sterner

Bottan

Monne Rodriguez

J.M.

Pellegrini

Schmidt

, Microengineered biosynthesized cellulose as anti-fibrotic in vivo protection for cardiac implantable electronic devices, Biomaterials 229 (2020), 119583.

20.

Esposito

Kennergren

Holmstrom

Nilsson

Eckerdal

and Thomsen

, Morphologic and immunohistochemical observations of tissues surrounding retrieved transvenous pacemaker leads, Journal of Biomedical Materials Research 63(5) (2002), 548–558.

21.

Mancini

M.C.

and Grubb

B.P.

, A technique for the prevention of automatic implantable cardioverter defibrillator generator migration, Pacing Clin Electrophysiol 13(7) (1990), 946–947.

22.

Kusumoto

F.M.

Schoenfeld

M.H.

Wilkoff

B.L.

Berul

C.I.

Birgersdotter-Green

U.M.

Carrillo

, HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction, Heart Rhythm 14(12) (2017), e503–e551.

23.

Borleffs

C.J.

Thijssen

de Bie

M.K.

van Rees

J.B.

van Welsenes

G.H.

van Erven

, Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications, Pacing Clin Electrophysiol 33(8) (2010), 1013–1019.

24.

Biefer

H.R.

Hurlimann

Grunenfelder

Salzberg

S.P.

Steffel

Falk

, Generator pocket adhesions of cardiac leads: Classification and correlation with transvenous lead extraction results, Pacing Clin Electrophysiol 36(9) (2013), 1111–1116.

25.

Maytin

, Device pocket scar predicts transvenous lead extraction difficulty, Journal of Innovations in Cardiac Rhythm Management 6(11) (2015), 2173–2177.

26.

Keiler

Schulze

Sombetzki

Heller

Tischer

Grabow

, Neointimal fibrotic lead encapsulation - Clinical challenges and demands for implantable cardiac electronic devices, J Cardiol 70(1) (2017), 7–17.

27.

Kuriyama

Ochiai

Inoue

Sakamoto

Yamamoto

Utsumi

, Characterization of the capsule surrounding smooth and textured tissue expanders and correlation with contracture, Plast Reconstr Surg Glob Open 5(7) (2017), e1403.

28.

CanGaroo Envelope: Aziyo Biologics; Available from: https://www.aziyo.com/products/electrophysiology/cangaroo/.

29.

Xiang

Catanzaro

J.N.

Elayi

Esquer Garrigos

and Sohail

M.R.

, Antibiotic-eluting envelopes to prevent cardiac-implantable electronic device infection: Past, present, and future, Cureus 13(2) (2021), e13088.

30.

Nayak

Beaser

A.D.

and Aziz

Z.A.

, Patient profiles in the utilization of the CanGaroo(R) envelope, Cureus 13(1) (2021), e12702.

31.

Hodde

J.P.

Record

R.D.

Liang

H.A.

and Badylak

S.F.

, Vascular endothelial growth factor in porcine-derived extracellular matrix, Endothelium 8(1) (2001), 11–24.

32.

Brown

B.N.

and Badylak

S.F.

, Extracellular matrix as an inductive scaffold for functional tissue reconstruction, Transl Res 163(4) (2014), 268–285.

33.

Badylak

S.F.

, Decellularized allogeneic and xenogeneic tissue as a bioscaffold for regenerative medicine: Factors that influence the host response, Ann Biomed Engng 42(7) (2014), 1517–1527.

34.

Piterina

A.V.

Cloonan

A.J.

Meaney

C.L.

Davis

L.M.

Callanan

Walsh

M.T.

, ECM-based materials in cardiovascular applications: Inherent healing potential and augmentation of native regenerative processes, Int J Mol Sci 10(10) (2009), 4375–4417.

35.

Voytik-Harbin

S.L.

Brightman

A.O.

Kraine

M.R.

Waisner

and Badylak

S.F.

, Identification of extractable growth factors from small intestinal submucosa, Journal of Cellular Biochemistry 67(4) (1997), 478–491.

36.

National Research Council (U.S.). Committee for the Update of the Guide for the Care and Use of Laboratory Animals, Institute for Laboratory Animal Research (U.S.), National Academies Press (U.S.). Guide for the care and use of laboratory animals. National Academies Press, Washington, D.C., 2011. Available from: http://grants.nih.gov/grants/olaw/Guide-for-the-Care-and-use-of-laboratory-animals.pdf.

37.

Bell

, Replicates and repeats, BMC Biol 14 (2016), 28.

38.

Golshan

Curtis

J.A.

Lianos

Rabbany

S.Y.

and de Guzman

R.C.

, Compressive strengths of PEG gels with glycerol and bioglass particles, J Mater Res 34(8) (2019), 1341–1352.

39.

Chapra

S.C.

, Applied Numerical Methods with MATLAB for Engineers and Scientists, Fourth edn, McGraw-Hill Education, New York, NY, 2018, xvi, 697 pages.

40.

Biocolor, Fastin Elastin Assay, 2015, p. 17.Product manual BIO.FAS.VER.O3-22September2015int: Available from: https://uploads-ssl.webflow.com/623c6aaf9b946bc877abcc61/627bb5ce9a70e11024be6e19_Fastin-manual-webopt.pdf.

41.

Halabi

C.M.

and Mecham

R.P.

, Elastin purification and solubilization, Methods Cell Biol 143 (2018), 207–222.

42.

de Guzman

R.C.

Merrill

M.R.

Richter

J.R.

Hamzi

R.I.

Greengauz-Roberts

O.K.

and Van Dyke

M.E.

, Mechanical and biological properties of keratose biomaterials, Biomaterials 32(32) (2011), 8205–8217.

43.

ab150686 Trichrome Stain (Connective Tissue Stain): Abcam [updated 18 September 2020], Version 3d: Available from: https://www.abcam.com/ps/products/150/ab150686/documents/Trichrome-Stain-Kit-protocol-book-v3d-ab150686%20(website).pdf.

44.

ab150667 Elastic (Connective Tissue Stain): Abcam [updated 14 August 2020] Version 3e: Available from: https://www.abcam.com/ps/products/150/ab150667/documents/Elastic-Staining-protocol-book-v3e-ab150667%20(website).pdf.

45.

Anti-Collagen I antibody ab233080: Abcam. Available from: https://www.abcam.com/collagen-i-antibody-ab233080.pdf.

46.

Mansfield

Attenburrow

Moger

Tirlapur

Urban

, The elastin network: Its relationship with collagen and cells in articular cartilage as visualized by multiphoton microscopy, Journal of Anatomy 215(6) (2009), 682–691.

47.

Merrilees

M.J.

Ching

P.S.

Beaumont

Hinek

Wight

T.N.

and Black

P.N.

, Changes in elastin, elastin binding protein and versican in alveoli in chronic obstructive pulmonary disease, Respir Res 9 (2008), 41.

48.

Rabbit specific HRP/DAB (ABC) Detection IHC Kit ab64261: Abcam. Available from: https://www.abcam.com/rabbit-specific-hrpdab-abc-detection-ihc-kit-ab64261.pdf.

49.

Rosenberg

L.K.

Bagger

Janfelt

Haedersdal

Olesen

U.H.

and Lerche

C.M.

, A comparison of human and porcine skin in laser-assisted drug delivery of chemotherapeutics, Lasers Surg Med 53(1) (2021), 162–170.

50.

Matsumoto

Sugita

and Nagayama

, Tensile properties of smooth muscle cells, elastin, and collagen fibers, in: Vascular Engineering: New Prospects of Vascular Medicine and Biology with a Multidiscipline Approach, K. Tanishita and K. Yamamoto (eds), Springer Japan, Tokyo, 2016, pp. 127–140.

51.

Wex

Arndt

Stoll

Bruns

and Kupriyanova

, Isotropic incompressible hyperelastic models for modelling the mechanical behaviour of biological tissues: A review, Biomed Tech (Berl) 60(6) (2015), 577–592.

52.

Bradycardia Therapy: Biotronik. Available from: https://www.biotronik.com/en-us/products/crm/bradycardia.

53.

Sawant

Hinz

Schonborn

Zeinert

Eckes

Krieg

, A story of fibers and stress: Matrix-embedded signals for fibroblast activation in the skin, Wound Repair Regen 29(4) (2021), 515–530.

54.

Deegan

and Riebman

J.B.

, CARD29: An Acellular Biologic Extracellular Matrix (ECM) envelope for cardiovascular implantable electronic devices: preclinical evaluation, ASAIO Journal 68(Supplement 2) (2022), 61.

55.

Imber

Schwager

R.G.

Guthrie Jr.

R.H.

and Gray

G.F.

, Fibrous capsule formation after subcutaneous implanation of synthetic materials in experimental animals, Plastic and Reconstructive Surgery 54(2) (1974), 183–186.

56.

Wang

and Zhang

, Transmural variation in elastin fiber orientation distribution in the arterial wall, Journal of the Mechanical Behavior of Biomedical Materials 77 (2018), 745–753.

57.

Alkhouli

Mansfield

Green

Bell

Knight

Liversedge

, The mechanical properties of human adipose tissues and their relationships to the structure and composition of the extracellular matrix, Am J Physiol Endocrinol Metab 305(12) (2013), E1427–E1435.

58.

Tompkins

McLean

Cheng

Brinker

J.A.

Marine

J.E.

Nazarian

, End-stage renal disease predicts complications in pacemaker and ICD implants, J Cardiovasc Electrophysiol 22(10) (2011), 1099–1104.

59.

Lin

Y.S.

Hung

S.P.

Chen

P.R.

Yang

C.H.

H.T.

Chang

P.C.

, Risk factors influencing complications of cardiac implantable electronic device implantation: Infection, pneumothorax and heart perforation: a nationwide population-based cohort study, Medicine (Baltimore) 93(27) (2014), e213.

60.

Sood

Martin

D.T.

Lampert

Curtis

J.P.

Parzynski

and Clancy

, Incidence and predictors of perioperative complications with transvenous lead extractions: Real-world experience with national cardiovascular data registry, Circ Arrhythm Electrophysiol 11(2) (2018), e004768.

61.

Poole

J.E.

Gleva

M.J.

Mela

Chung

M.K.

Uslan

D.Z.

Borge

, Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: Results from the REPLACE registry, Circulation 122(16) (2010), 1553–1561.

62.

Wang

Hahn

and Zhang

, Mechanical properties of arterial elastin with water loss, Journal of Biomechanical Engineering 140(4) (2018), 0410121–0410128.

63.

Langton

A.K.

Alessi

Hann

Chien

A.L.

Kang

Griffiths

C.E.M.

, Aging in skin of color: Disruption to elastic fiber organization is detrimental to skin’s biomechanical function, J Invest Dermatol 139(4) (2019), 779–788.

64.

Kamino

Tam

Roses

and Toussaint

, Elastic fiber pattern in regressing melanoma: A histochemical and immunohistochemical study, J Cutan Pathol 37(7) (2010), 723–729.

65.

Walters

Pulitzer

and Kamino

, Elastic fiber pattern in scleroderma/morphea, J Cutan Pathol 36(9) (2009), 952–957.